Akebia Therapeutics Inc.
AKBA | NASDAQ
$0.99
+$0.05 (+5.49%)
Sep 22, 2026, 1:36 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 155.55M | 162.64M | 184.84M | 166.44M | 137.31M | 113.37M | 51.87M | 34.02M | 39.5M | 41.96M | 42.93M | 46.53M | 53.57M | 56.95M | 90.47M | 144.76M | 143.89M | 174.56M | 149.8M | 207.2M | 246.99M | 252.77M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.69M | 1.69M | n/a | 1.67M | n/a | n/a | n/a | n/a | 1.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 53.75M | 56.57M | 59.68M | 40.46M | 42.5M | 36.66M | 37.38M | 25.46M | 17.78M | 11.79M | 12.42M | 3.86M | 1.63M | 5.24M | 5.37M | 26.28M | 34.95M | 39.42M | 50.42M | 69.6M | 67.47M | 39.64M |
Receivables | 53.51M | 62.54M | 47.03M | 66.22M | 72.81M | 61.54M | 34.37M | 32.17M | 29.77M | 26.62M | 39.29M | 22.59M | 19.57M | 17.78M | 40.28M | 23.09M | 81.87M | 64.58M | 51.58M | 49.69M | 35.01M | 35.23M |
Inventory | 13.02M | 13M | 15.61M | 18.64M | 16.71M | 19.73M | 16.24M | 20.49M | 23.87M | 25.53M | 15.69M | 18.44M | 20.91M | 20.6M | 21.57M | 40.04M | 36.27M | 39.42M | 36.63M | 33.69M | 37.9M | 44.81M |
Other Current Assets | n/a | 5.31M | 5.47M | 7.03M | 7.83M | 7.92M | 7.32M | 13.44M | 7.33M | 4.81M | 5.75M | 2.6M | 24.4M | 2.7M | 32.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 229.55M | 243.48M | 252.96M | 258.34M | 234.66M | 203.78M | 113.83M | 100.12M | 112.1M | 112.94M | 118.15M | 109.6M | 118.45M | 120.72M | 185.18M | 237.51M | 304.16M | 302.69M | 271.15M | 330.08M | 331.08M | 365.02M |
Property-Plant & Equipment | 7.31M | 3.42M | 4.89M | 6.31M | 7.7M | 9.02M | 10.42M | 11.83M | 13.26M | 14.66M | 16.05M | 17.44M | 18.81M | 32.77M | 34.37M | 35.96M | 37.53M | 39.08M | 40.61M | 30.39M | 32.11M | 33.84M |
Goodwill & Intangibles | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M | 68.06M | 77.07M | 86.08M | 95.09M | 104.1M | 113.11M | 118.13M | 131.13M | 136.15M | 145.16M | 154.17M | 167.17M | 172.19M | 181.2M | 190.21M |
Total Long-Term Assets | 120.11M | 119.04M | 123.61M | 105.82M | 110.94M | 106.4M | 106.84M | 107.02M | 108.1M | 112.53M | 123.55M | 125.4M | 135.27M | 156.14M | 170.87M | 198.38M | 217.64M | 232.67M | 258.2M | 272.18M | 280.79M | 263.69M |
Total Assets | 349.66M | 362.52M | 376.57M | 364.15M | 345.6M | 310.19M | 220.67M | 207.14M | 220.2M | 225.48M | 241.7M | 235M | 253.71M | 276.86M | 356.05M | 435.89M | 521.8M | 535.36M | 529.35M | 602.27M | 611.86M | 628.7M |
Account Payables | 9.42M | 8.39M | 21.19M | 10.09M | 11.55M | 12.66M | 15.18M | 13.49M | 10.11M | 11.88M | 14.64M | 9.04M | 11.78M | 12.58M | 18.02M | 19.71M | 24.94M | 19.47M | 33.59M | 28.81M | 41.98M | 30.54M |
Deferred Revenue | 6.17M | 4.5M | 2.68M | 3.88M | 5.53M | 1.24M | n/a | n/a | n/a | 695K | n/a | n/a | 23.3M | n/a | 3.74M | 1.27M | 5.05M | 10.44M | 20.91M | 15.69M | 11.87M | 18.25M |
Short-Term Debt | 24.81M | 12.5M | n/a | n/a | n/a | n/a | 4.31M | 2.24M | 2.01M | n/a | 17.5M | 8M | 28.76M | 24M | 32M | 65.95M | 98.16M | 97.85M | 97.54M | n/a | n/a | n/a |
Other Current Liabilities | 10.67M | 148.51M | 107.83M | 40.15M | 35.72M | 47.39M | 22.75M | 44.69M | 62.77M | 28.71M | 41.18M | 14.57M | 21.77M | 1.29M | 52.53M | 38.9M | 40.42M | 42.74M | 31.18M | 44.24M | 39.08M | 39.23M |
Total Current Liabilities | 160.87M | 173.88M | 162.94M | 133.38M | 118.72M | 91.23M | 80.91M | 65.71M | 107.3M | 66.49M | 99.87M | 79.7M | 92.18M | 82.94M | 129.54M | 187.97M | 233.68M | 253.91M | 261.05M | 189.21M | 165.6M | 172.68M |
Long-Term Debt | 24.75M | n/a | 48.25M | 47.64M | 47.06M | 46.51M | 175.47M | 38.36M | 91.13M | 30.15M | 17.18M | 90.67M | 75.03M | 83.36M | 34.08M | 58.24M | 56.74M | n/a | 53.08M | 97.23M | 96.92M | 96.61M |
Other Long-Term Liabilities | 134.62M | 161.26M | 132.77M | 141.54M | 149.92M | 145.74M | 9.93M | 148.54M | 49.22M | 105.17M | 102.99M | 93.82M | 58.53M | 97.49M | 114.95M | 101.86M | 94.05M | 157.39M | 86.03M | 130.46M | 136.39M | 103.04M |
Total Long-Term Liabilities | 163.78M | 161.26M | 181.02M | 189.18M | 197.65M | 194.38M | 188.94M | 191.84M | 146.65M | 186.25M | 172.42M | 194.72M | 188.34M | 208.27M | 221.29M | 234.08M | 225.82M | 255.33M | 194.29M | 275.91M | 271.64M | 242.13M |
Total Liabilities | 324.64M | 335.15M | 343.96M | 322.56M | 316.37M | 285.6M | 269.86M | 257.54M | 253.95M | 252.74M | 272.29M | 274.42M | 280.52M | 291.21M | 350.82M | 422.04M | 459.5M | 509.24M | 455.34M | 465.12M | 437.23M | 414.81M |
Total Debt | 53.96M | 12.5M | 51.8M | 52.58M | 53.36M | 54.15M | 188.73M | 50.82M | 104.62M | 42.85M | 48.12M | 113.76M | 115.27M | 139.93M | 99.78M | 159.13M | 191.06M | 135.19M | 189.13M | 123.21M | 124.23M | 125.22M |
Book Value | 25.02M | 27.38M | 32.61M | 41.59M | 29.22M | 24.58M | -49.19M | -50.4M | -33.75M | -27.26M | -30.58M | -39.42M | -26.81M | -14.35M | 5.23M | 13.85M | 62.3M | 26.12M | 74.01M | 137.15M | 174.63M | 213.89M |
Book Value Per Share | 0.09 | 0.10 | 0.12 | 0.15 | 0.11 | 0.10 | -0.22 | -0.24 | -0.16 | -0.13 | -0.16 | -0.21 | -0.14 | -0.08 | 0.03 | 0.08 | 0.33 | 0.15 | 0.42 | 0.79 | 1.08 | 1.39 |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 2K | 2K | 2K |
Retained Earnings | -1.7B | -1.69B | -1.68B | -1.67B | -1.67B | -1.67B | -1.68B | -1.66B | -1.64B | -1.63B | -1.61B | -1.61B | -1.6B | -1.58B | -1.56B | -1.55B | -1.49B | -1.52B | -1.46B | -1.39B | -1.33B | -1.25B |
Comprehensive Income | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 9K |
Shareholders Equity | 25.02M | 27.38M | 32.61M | 41.59M | 29.22M | 24.58M | -49.19M | -50.4M | -33.75M | -27.26M | -30.58M | -39.42M | -26.81M | -14.35M | 5.23M | 13.85M | 62.3M | 26.12M | 74.01M | 137.15M | 174.63M | 213.89M |
Total Investments | n/a | n/a | n/a | n/a | 1.69M | 1.69M | n/a | 1.67M | n/a | n/a | n/a | n/a | 1.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M |
Add to Watchlist
Select watchlists to add or remove AKBA